Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Simm

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Hormone Research in Paediatrics|January 28, 2021
Outcomes of Zoledronic Acid Use in Paediatric ConditionsAngelina Lim, Peter J Simm, Simon James, et al.
Hormone Research in Paediatrics|July 2, 2020
Effect of Testosterone Treatment for Delayed Puberty in Duchenne Muscular DystrophySamantha Lai-Ka Lee, Angelina Lim, Craig Munns, et al.
Journal of Paediatrics and Child Health|January 3, 2018
Outcomes of standardised approach to metabolic bone disease of prematurityLit Kim Chin, John Doan, Yvonne Sl Teoh, et al.
Journal of Paediatrics and Child Health|February 27, 2025
X-Linked Hypophosphataemia and Burosumab: A Systemic Disease With a New TreatmentJessica L Sandy, Andrew Biggin, Aris Siafarikas, et al.
Journal of Paediatrics and Child Health|February 20, 2014
Geography does not limit optimal diabetes care: use of a tertiary centre model of care in an outreach service for type 1 diabetes mellitusPeter J Simm, Nicole Wong, Lynne Fraser, et al.
Journal of Paediatrics and Child Health|April 15, 2022
Clinical practice guidelines for paediatric X-linked hypophosphataemia in the era of burosumabJessica L Sandy, Peter J Simm, Andrew Biggin, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|July 2, 2009
Neonatal hyperinsulinaemic hypoglycaemia and monogenic diabetes due to a heterozygous mutation of the HNF4A geneJennifer J Conn, Peter J Simm, Jeremy J N Oats, et al.
Pediatric Pulmonology|March 16, 2021
The clinical features that contribute to poor bone health in young Australians living with cystic fibrosis: A recommendation for BMD screeningGabby Atlas, Matthew Yap, Angelina Lim, et al.
BMJ Open|July 6, 2019
pQCT bone geometry and strength: population epidemiology and concordance in Australian children aged 11-12 years and their parentsJennifer Vlok, Peter J Simm, Kate Lycett, et al.
Bone|August 9, 2011
Zoledronic acid improves bone mineral density, reduces bone turnover and improves skeletal architecture over 2 years of treatment in children with secondary osteoporosisPeter J Simm, Jesper Johannesen, Julie Briody, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Hormone Research in Paediatrics|January 28, 2021
Outcomes of Zoledronic Acid Use in Paediatric ConditionsAngelina Lim, Peter J Simm, Simon James, et al.
Hormone Research in Paediatrics|July 2, 2020
Effect of Testosterone Treatment for Delayed Puberty in Duchenne Muscular DystrophySamantha Lai-Ka Lee, Angelina Lim, Craig Munns, et al.
Journal of Paediatrics and Child Health|January 3, 2018
Outcomes of standardised approach to metabolic bone disease of prematurityLit Kim Chin, John Doan, Yvonne Sl Teoh, et al.
Journal of Paediatrics and Child Health|February 27, 2025
X-Linked Hypophosphataemia and Burosumab: A Systemic Disease With a New TreatmentJessica L Sandy, Andrew Biggin, Aris Siafarikas, et al.
Journal of Paediatrics and Child Health|February 20, 2014
Geography does not limit optimal diabetes care: use of a tertiary centre model of care in an outreach service for type 1 diabetes mellitusPeter J Simm, Nicole Wong, Lynne Fraser, et al.
Journal of Paediatrics and Child Health|April 15, 2022
Clinical practice guidelines for paediatric X-linked hypophosphataemia in the era of burosumabJessica L Sandy, Peter J Simm, Andrew Biggin, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|July 2, 2009
Neonatal hyperinsulinaemic hypoglycaemia and monogenic diabetes due to a heterozygous mutation of the HNF4A geneJennifer J Conn, Peter J Simm, Jeremy J N Oats, et al.
Pediatric Pulmonology|March 16, 2021
The clinical features that contribute to poor bone health in young Australians living with cystic fibrosis: A recommendation for BMD screeningGabby Atlas, Matthew Yap, Angelina Lim, et al.
BMJ Open|July 6, 2019
pQCT bone geometry and strength: population epidemiology and concordance in Australian children aged 11-12 years and their parentsJennifer Vlok, Peter J Simm, Kate Lycett, et al.
Bone|August 9, 2011
Zoledronic acid improves bone mineral density, reduces bone turnover and improves skeletal architecture over 2 years of treatment in children with secondary osteoporosisPeter J Simm, Jesper Johannesen, Julie Briody, et al.
Pageof 4